Maxacalcitol/Betamethasone butyrate propionate

马沙骨化醇/倍他米松丁酸丙酸酯

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMaxacalcitol/Betamethasone butyrate propionate
Drug Alias Name丁酸盐丙酸盐倍他米松/马沙骨化醇Maxacalcitol and Betamethasone Butyrate PropionateBetamethasone Butyrate Propionate/MaxacalcitolMarduoxM-8010 +[6] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionVitamin D3 analoguesVitamin D receptor agonistsGlucocorticoid receptor agonists
TargetsGlucocorticoid receptorVitamin D receptor
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsPsoriasis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2016/03/28
Country/TerritoryJapan
CombinationsYes MaxacalcitolBetamethasone butyrate propionate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChugai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChugai Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeD05
Related LinksKEGG